Pimagedine Completed Phase 1 Trials for Diabetic Retinopathy (DR) Basic Science

IndicationsStatusPurposePhase
CompletedBasic Science1
clinicaltrials.gov IdentifierTitleDrugs
NCT02099981Restoration of Retinal Vascular Responses in Type 1 Diabetic Patients